Fluoxetine Essay in Children With Autism

Summary

This study is a comparative, double blind, placebo controlled trial of 6-months duration designed to evaluate 1) the effects of fluoxetine in 5 to 12 years old autistic children, 2) the effects of fluoxetine on serotoninergic parameters, 3) cerebral metabolic changes (rCBF measurements with PET) induced by the treatment.

Timeline

Start

2009-09

Primary completion

2010-11

Completion

2011-11

Drugs

Indications